TUB-010, a novel antibody drug conjugate with reduced nonspecific toxicity profile based on Tub-tag technology widens the therapeutic window of targeting CD30 Meeting Abstract


Authors: Gerlach, M.; Schmitt, S.; Cyprys, P.; Kasper, M. A.; Mai, I.; Vermeer, M. H.; Horwitz, S. M.; Fingerle-Rowson, G.; Vogl, A.; Schumacher, D.; Helma-Smets, J.
Abstract Title: TUB-010, a novel antibody drug conjugate with reduced nonspecific toxicity profile based on Tub-tag technology widens the therapeutic window of targeting CD30
Meeting Title: EORTC CLTG Meeting on Cutaneous Lymphomas: From Molecules to PROs
Journal Title: European Journal of Cancer
Volume: 173
Issue: Suppl. 1
Meeting Dates: 2022 Sep 22-24
Meeting Location: Madrid, Spain
ISSN: 0959-8049
Publisher: Elsevier Inc.  
Date Published: 2022-09-01
Start Page: S27
Language: English
ACCESSION: WOS:000872008600058
PROVIDER: wos
DOI: 10.1016/S0959-8049(22)00604-9
Notes: Meeting Abstract: Ther-O-15 -- Oral Presentation: Therapeutics -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Steven M Horwitz
    645 Horwitz